Sun Pharmaceutical Industries said that it has received approval from the U.S. Food and Drug Administration (US FDA) for LEQSELVI (deuruxolitinib), an oral JAK Inhibitor for the treatment of severe alopecia areata.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
